[ASAP] Reduction-Responsive Docetaxel Prodrug Encapsulated within Human Serum Albumin Nanoparticles for Cancer Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01107
Source: Molecular Pharmaceutics - Category: Drugs & Pharmacology Authors: Yanhao Zhang, Hao Zhang, Ji Wang, Chao Liu, Hanlei Xing, Yuhao Jiang, and Xinsong Li Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Docetaxel | Drugs & Pharmacology | Nanotechnology | Taxotere